Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells

被引:46
作者
Firon, M
Shaharabany, M
Altstock, RT
Horev, J
Abramovici, A
Resau, JH
Vande Woude, GF
Tsarfaty, I [1 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Dept Human Microbiol, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel
[3] NCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USA
基金
以色列科学基金会;
关键词
Met; HGF/SF; dominant negative; tubulogenesis; breast cancer cells;
D O I
10.1038/sj.onc.1203557
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Activation of the Met tyrosine kinase growth factor receptor by its ligand HGF/SF has been shown to increase in vitro invasiveness in epithelial cell lines. To study the effect of Met-HGF/SF signaling in breast cancer cells, we transfected met, hgf/sf and dominant negative (DN) forms of met into the poorly differentiated metastatic murine mammary adenocarcinoma cell line DA3, These cells express moderate levels of endogenous Met, which is rapidly phosphorylated in response to HGF/SF treatment. Met+hgf/sf transfection results in significantly increased tumorigenic and metastatic activity in vivo accompanied by reduced tubule formation. DA3 cells transfected with DN forms of Met (DN-DA3) exhibit reduced Met phosphorylation following exposure to HGF/SF, Furthermore, as compared to the parental cells, the DN-DA3 cells exhibit diminished in vitro scattering and invasiveness, while in vitro they display greatly reduced tumorigenicity and spontaneous metastasis, Tumors emanating from DN-DA3 cells injected to BALB/C mice are highly differentiated and display extensive tubule formation. These results suggest that Met-HGF/SF signaling is a determining factor in the delicate balance between differentiation/tubule formation and tumorigenicity-metastasis.
引用
收藏
页码:2386 / 2397
页数:12
相关论文
共 66 条
[1]
ALBINI A, 1987, CANCER RES, V47, P3239
[2]
EXPRESSION OF A DOMINANT NEGATIVE MUTANT OF THE FGF RECEPTOR DISRUPTS MESODERM FORMATION IN XENOPUS EMBRYOS [J].
AMAYA, E ;
MUSCI, TJ ;
KIRSCHNER, MW .
CELL, 1991, 66 (02) :257-270
[3]
GENE DIAGNOSTICS PROVIDE NEW INSIGHTS INTO BREAST-CANCER PROGNOSIS AND THERAPY [J].
BENZ, CC ;
BRANDT, BH ;
ZANKER, KS .
GENE, 1995, 159 (01) :3-7
[4]
BERDICHEVSKY F, 1994, J CELL SCI, V107, P3557
[5]
Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO
[6]
2-E
[7]
LOSS OF HETEROZYGOSITY ON CHROMOSOME-7Q AND AGGRESSIVE PRIMARY BREAST-CANCER [J].
BIECHE, I ;
CHAMPEME, MH ;
MATIFAS, F ;
HACENE, K ;
CALLAHAN, R ;
LIDEREAU, R .
LANCET, 1992, 339 (8786) :139-143
[8]
ESSENTIAL ROLE FOR THE C-MET RECEPTOR IN THE MIGRATION OF MYOGENIC PRECURSOR CELLS INTO THE LIMB BUD [J].
BLADT, F ;
RIETHMACHER, D ;
ISENMANN, S ;
AGUZZI, A ;
BIRCHMEIER, C .
NATURE, 1995, 376 (6543) :768-771
[9]
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway [J].
Boccaccio, C ;
Andò, M ;
Tamagnone, L ;
Bardelli, A ;
Michieli, P ;
Battistini, C ;
Comoglio, PM .
NATURE, 1998, 391 (6664) :285-288
[10]
HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH [J].
BUSSOLINO, F ;
DIRENZO, MF ;
ZICHE, M ;
BOCCHIETTO, E ;
OLIVERO, M ;
NALDINI, L ;
GAUDINO, G ;
TAMAGNONE, L ;
COFFER, A ;
COMOGLIO, PM .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :629-641